Chemo-Free Therapy in Pediatric Acute Promyelocytic Leukemia Cristina Ferrario Medscape Europe logo June 12, 2026

https://www.medscape.com/viewarticle/chemo-free-therapy-pediatric-acute-promyelocytic-leukemia-2026a1000jvy STOCKHOLM —Eliminating anthracyclines from the treatment regimen of children and adolescents newly diagnosed with acute promyelocytic leukemia (APL) is feasible and yields excellent positive outcomes in standard-risk and high-risk patients, new data suggest. At the 2026 European Hematology Association Congress, Franco Locatelli presented the final results of the ICC-APL-02 trial, paving the way for a new treatment approach that dispenses with conventional chemotherapy in this pediatric population. European Hematology Association (EHA) 2026 Congress https://www.medscape.com/c25/p14/european-hematology-association-eha-2026-congress-2026a1000g3s